StemCyte International, Ltd. (TPEX:4178)
Taiwan · Delayed Price · Currency is TWD 25.80
-0.05 (-0.19%)
At close: Apr 17, 2026
StemCyte International Revenue
In the year 2025, StemCyte International had annual revenue of 368.91M TWD, down -3.60%. StemCyte International had revenue of 87.21M in the quarter ending December 31, 2025, a decrease of -15.67%.
Revenue
368.91M
Revenue Growth
-3.60%
P/S Ratio
13.46
Revenue / Employee
n/a
Employees
n/a
Market Cap
4.97B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 368.91M | -13.77M | -3.60% |
| Dec 31, 2024 | 382.69M | 19.91M | 5.49% |
| Dec 31, 2023 | 362.78M | 15.09M | 4.34% |
| Dec 31, 2022 | 347.69M | -509.38M | -59.43% |
| Dec 31, 2013 | 857.07M | 124.33M | 16.97% |
| Dec 31, 2012 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2011 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shieh Yih Machinery Industry | 4.03B |
| Welldone Company | 3.19B |
| Ubright Optronics | 3.01B |
| Golden Long Teng Development | 2.70B |
| Aethertek technology co. | 1.70B |
| Best Precision Industrial | 923.35M |
| Jtron Technology | 594.39M |
| Eastern Union Interactive | 565.11M |